Item
1. Financial Statements
INNOVATIVE
EYEWEAR, INC.
CONDENSED
BALANCE SHEETS
September
30, 2022 (Unaudited) and December 31, 2021
| |
| | | |
| | |
| |
2022 | | |
2021 | |
TOTAL
ASSETS | |
| | | |
| | |
Current
Assets | |
| | | |
| | |
Cash
and cash equivalents | |
$ | 4,976,224 | | |
$ | 79,727 | |
Accounts
receivable | |
| 187,592 | | |
| 43,394 | |
Prepaid
expenses | |
| 316,183 | | |
| 68,381 | |
Deferred
offering costs | |
| - | | |
| 111,149 | |
Inventory
prepayment | |
| 197,750 | | |
| 64,715 | |
Inventory | |
| 422,900 | | |
| 275,501 | |
Other
current assets | |
| 1,460 | | |
| 1,460 | |
Total
Current Assets | |
| 6,102,109 | | |
| 644,327 | |
| |
| | | |
| | |
Non-Current
Assets | |
| | | |
| | |
Patent
costs, net | |
| 120,188 | | |
| 87,306 | |
Capitalized
software costs | |
| 97,323 | | |
| 72,400 | |
Property
and equipment, net | |
| 98,281 | | |
| 20,284 | |
TOTAL
ASSETS | |
$ | 6,417,901 | | |
$ | 824,317 | |
| |
| | | |
| | |
LIABILITIES
AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
Liabilities | |
| | | |
| | |
Current
Liabilities | |
| | | |
| | |
Accounts
payable and accrued expenses | |
$ | 485,911 | | |
$ | 167,050 | |
Due
to Parent and Affiliates | |
| 198,932 | | |
| 160,722 | |
Related
party convertible debt | |
| 166,206 | | |
| 289,029 | |
Total
Current Liabilities | |
| 851,049 | | |
| 616,801 | |
| |
| | | |
| | |
TOTAL
LIABILITIES | |
| 851,049 | | |
| 616,801 | |
| |
| | | |
| | |
Commitments
and contingencies | |
| - | | |
| - | |
| |
| | | |
| | |
Stockholders’
Equity | |
| | | |
| | |
Common
stock (par value $0.00001, 50,000,000 shares authorized, and 7,307,157 and 6,060,187 shares issued and outstanding as of September
30, 2022 and December 31, 2021, respectively) | |
| 73 | | |
| 60 | |
Additional
paid-in capital | |
| 14,000,167 | | |
| 4,842,836 | |
Stock
subscription receivable | |
| (4,542 | ) | |
| (11,226 | ) |
Accumulated
deficit | |
| (8,428,846 | ) | |
| (4,624,154 | ) |
TOTAL
STOCKHOLDERS’ EQUITY | |
| 5,566,852 | | |
| 207,516 | |
| |
| | | |
| | |
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY | |
$ | 6,417,901 | | |
$ | 824,317 | |
See
accompanying Notes to the Financial Statements.
INNOVATIVE
EYEWEAR, INC.
CONDENSED
STATEMENTS OF OPERATIONS
For
the three and nine months ended September 30, 2022 and 2021
(Unaudited)
| |
| | | |
| | | |
| | | |
| | |
| |
Three
Months Ended
September 30, | | |
Nine
Months Ended
September 30, | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
Revenues,
net | |
$ | 151,957 | | |
$ | 171,033 | | |
$ | 592,720 | | |
$ | 415,185 | |
Less:
Cost of Goods Sold | |
| (129,092 | ) | |
| (130,223 | ) | |
| (452,218 | ) | |
| (332,378 | ) |
Gross
Profit | |
| 22,865 | | |
| 40,810 | | |
| 140,502 | | |
| 82,807 | |
| |
| | | |
| | | |
| | | |
| | |
Operating
Expenses: | |
| | | |
| | | |
| | | |
| | |
General
and administrative | |
| (479,983 | ) | |
| (584,927 | ) | |
| (1,797,091 | ) | |
| (883,356 | ) |
Sales
and marketing | |
| (568,901 | ) | |
| (512,937 | ) | |
| (1,545,615 | ) | |
| (903,795 | ) |
Research
& development | |
| (304,691 | ) | |
| (9,224 | ) | |
| (393,058 | ) | |
| (36,121 | ) |
Related
party management fee | |
| (35,000 | ) | |
| (25,000 | ) | |
| (105,000 | ) | |
| (84,975 | ) |
Total
Operating Expenses | |
| (1,388,575 | ) | |
| (1,132,088 | ) | |
| (3,840,764 | ) | |
| (1,908,247 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other
Expense | |
| (735 | ) | |
| - | | |
| (3,293 | ) | |
| - | |
Interest
Expense | |
| (37,876 | ) | |
| (9,502 | ) | |
| (101,137 | ) | |
| (33,654 | ) |
Total
Other Expenses | |
| (38,611 | ) | |
| (9,502 | ) | |
| (104,430 | ) | |
| (33,654 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net
Loss | |
$ | (1,404,321 | ) | |
$ | (1,100,780 | ) | |
$ | (3,804,692 | ) | |
$ | (1,859,094 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted
average number of shares outstanding | |
| 6,673,020 | | |
| 5,673,070 | | |
| 6,266,709 | | |
| 5,033,823 | |
Earnings
per share, basic and diluted | |
$ | (0.21 | ) | |
$ | (0.19 | ) | |
$ | (0.61 | ) | |
$ | (0.37 | ) |
See
accompanying Notes to the Financial Statements.
INNOVATIVE
EYEWEAR, INC.
CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
For
the three and nine months ended September 30, 2022 and 2021
(Unaudited)
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
Common
Stock | | |
Additional
Paid-in | | |
Stock
Subscription | | |
Accumulated | | |
Total
Stockholders’
Equity | |
| |
Shares | | |
Amount | | |
Capital | | |
Receivable | | |
Deficit | | |
(Deficit) | |
Balances,
January 1, 2022 | |
| 6,060,187 | | |
$ | 60 | | |
$ | 4,842,836 | | |
$ | (11,226 | ) | |
$ | (4,624,154 | ) | |
$ | 207,516 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net
Loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,206,559 | ) | |
| (1,206,559 | ) |
Stock
based compensation | |
| - | | |
| - | | |
| 416,951 | | |
| - | | |
| - | | |
| 416,951 | |
Balances,
March 2022 | |
| 6,060,187 | | |
$ | 60 | | |
$ | 5,259,787 | | |
$ | (11,226 | ) | |
$ | (5,830,713 | ) | |
$ | (582,092 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,193,812 | ) | |
| (1,193,812 | ) |
Stock
based compensation | |
| - | | |
| - | | |
| 416,951 | | |
| - | | |
| - | | |
| 416,951 | |
Collection
of stock subscription receivable | |
| - | | |
| - | | |
| - | | |
| 6,684 | | |
| - | | |
| 6,684 | |
Balances,
June 30, 2022 | |
| 6,060,187 | | |
$ | 60 | | |
$ | 5,676,738 | | |
$ | (4,542 | ) | |
$ | (7,024,525 | ) | |
$ | (1,352,269 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Shares
issued for convertible note exercise | |
| 266,970 | | |
| 3 | | |
| 2,002,277 | | |
| - | | |
| - | | |
| 2,002,280 | |
Initial
public offering (see Note 10) | |
| 980,000 | | |
| 10 | | |
| 6,015,908 | | |
| - | | |
| - | | |
| 6,015,918 | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,404,321 | ) | |
| (1,404,321 | ) |
Stock
based compensation | |
| - | | |
| - | | |
| 305,244 | | |
| - | | |
| - | | |
| 305,244 | |
Balances,
September 30, 2022 | |
| 7,307,157 | | |
$ | 73 | | |
$ | 14,000,167 | | |
$ | (4,542 | ) | |
$ | (8,428,846 | ) | |
$ | 5,566,852 | |
Balances,
January 1, 2021 | |
| 4,131,469 | | |
$ | 41 | | |
$ | 845,417 | | |
$ | (20,647 | ) | |
$ | (1,379,648 | ) | |
$ | (554,837 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Issuance
of shares net of offering costs of $217,958 | |
| 542,863 | | |
| 5 | | |
| 307,126 | | |
| (29,248 | ) | |
| - | | |
| 277,883 | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (221,713 | ) | |
| (221,713 | ) |
Stock
based compensation | |
| - | | |
| - | | |
| 38,065 | | |
| - | | |
| - | | |
| 38,065 | |
Balances,
March 2021 | |
| 4,674,332 | | |
$ | 46 | | |
$ | 1,190,608 | | |
$ | (49,895 | ) | |
$ | (1,601,361 | ) | |
$ | (460,602 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Shares
issued for convertible note exercise | |
| 778,500 | | |
| 8 | | |
| 778,492 | | |
| - | | |
| - | | |
| 778,500 | |
Issuance
of shares, net of offering costs of $28,230 | |
| 167,385 | | |
| 2 | | |
| 130,340 | | |
| (8,861 | ) | |
| - | | |
| 121,481 | |
Stock
based compensation | |
| - | | |
| - | | |
| 160,934 | | |
| - | | |
| - | | |
| 160,934 | |
Collection
of stock subscription receivable | |
| - | | |
| - | | |
| - | | |
| 40,765 | | |
| - | | |
| 40,765 | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (536,600 | ) | |
| (536,600 | ) |
Balances,
June 30, 2021 | |
| 5,620,217 | | |
$ | 56 | | |
$ | 2,260,374 | | |
$ | (17,991 | ) | |
$ | (2,137,961 | ) | |
$ | 104,478 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Shares
issued for convertible note exercise | |
| 140,449 | | |
| 1 | | |
| 500,001 | | |
| - | | |
| - | | |
| 500,002 | |
Issuance
of shares, net of offering costs of $93,341 | |
| 41,011 | | |
| 1 | | |
| 38,691 | | |
| (7,295 | ) | |
| - | | |
| 31,397 | |
Stock
based compensation | |
| - | | |
| - | | |
| 495,775 | | |
| - | | |
| - | | |
| 495,775 | |
Net
loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| (1,100,781 | ) | |
| (1,100,781 | ) |
Balances,
September 30, 2021 | |
| 5,801,677 | | |
$ | 58 | | |
$ | 3,294,841 | | |
$ | (25,286 | ) | |
$ | (3,238,742 | ) | |
$ | 30,871 | |
See
accompanying Notes to the Financial Statements.
INNOVATIVE
EYEWEAR, INC.
CONDENSED
STATEMENTS OF CASH FLOWS (Unaudited)
For
the nine months ended September 30, 2022 and 2021
| |
| | | |
| | |
| |
2022 | | |
2021 | |
Operating
Activities | |
| | | |
| | |
Net
Loss | |
$ | (3,804,692 | ) | |
$ | (1,859,094 | ) |
Adjustments
to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Amortization | |
| 7,060 | | |
| 6,218 | |
Depreciation | |
| 12,566 | | |
| - | |
Non
cash interest expense | |
| 37,876 | | |
| 38,621 | |
Stock
based compensation expense | |
| 1,139,145 | | |
| 694,774 | |
Expenses
paid by parent and affiliates | |
| 828,155 | | |
| 631,765 | |
Changes
in operating assets and liabilities: | |
| | | |
| | |
Accounts
receivable | |
| (144,198 | ) | |
| (27,069 | ) |
Accounts
payable and accrued expenses | |
| 345,497 | | |
| 25,707 | |
Prepaid
expenses | |
| (247,802 | ) | |
| (26,000 | ) |
Inventory | |
| (280,434 | ) | |
| (243,253 | ) |
Other
current assets | |
| - | | |
| (20,065 | ) |
Deferred
revenue | |
| - | | |
| 17,950 | |
Deferred
offering costs | |
| 111,149 | | |
| (50,000 | ) |
Net
cash flows from operating activities | |
| (1,995,678 | ) | |
| (810,446 | ) |
| |
| | | |
| | |
Investing
Activities | |
| | | |
| | |
Patent
costs | |
| (39,942 | ) | |
| (13,584 | ) |
Purchases
of property and equipment | |
| (90,563 | ) | |
| (10,662 | ) |
Capitalized
software expenditures | |
| (24,923 | ) | |
| (63,000 | ) |
Net
cash flows from investing activities | |
| (155,428 | ) | |
| (87,246 | ) |
| |
| | | |
| | |
Financing
Activities | |
| | | |
| | |
Proceeds
from issuance of shares, net of offering expenses | |
| 6,015,919 | | |
| 430,761 | |
Collection
of stock subscription receivable | |
| 6,684 | | |
| 40,765 | |
Proceeds
from related party convertible debt | |
| 1,475,000 | | |
| 521,000 | |
Repayment
of related party convertible debt | |
| (450,000 | ) | |
| (52,801 | ) |
Repayments
of amounts Due to Parent and Affiliates | |
| - | | |
| (4,000 | ) |
Net
cash flows from financing activities | |
| 7,047,603 | | |
| 935,725 | |
| |
| | | |
| | |
Net
Change In Cash | |
| 4,896,497 | | |
| 38,033 | |
| |
| | | |
| | |
Cash
at Beginning of Period | |
$ | 79,727 | | |
$ | 27,023 | |
Cash
at End of Period | |
$ | 4,976,224 | | |
$ | 65,056 | |
| |
| | | |
| | |
Significant
Non-Cash Transaction | |
| | | |
| | |
Expenses
paid for by Parent reported as increase in Due to Parent and Affiliates and related party convertible debt | |
| 828,155 | | |
| 631,765 | |
Shares
issued from conversion of related party convertible debt | |
| 2,002,280 | | |
| 1,278,502 | |
See
accompanying Notes to the Financial Statements.
INNOVATIVE
EYEWEAR, INC.
NOTES
TO THE FINANCIAL STATEMENTS
September
30, 2022 and 2021 (Unaudited)
NOTE
1 – GENERAL INFORMATION
Innovative
Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under
the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers
to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd
Ltd. (the “Parent” or “Lucyd”), a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively,
the “Parent and Affiliates”), which currently owns approximately 71% of our issued and outstanding shares of common stock.
Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of
Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying condensed balance sheet as of December 31, 2021 (which has been derived from audited financial statements) and the unaudited
interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X
promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and
regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary
for a comprehensive presentation of financial position, results of operations, or cash flows.
In
the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the periods
presented have been included. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative
of the results to be expected for future periods or the full year.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly
given the significant social and economic disruptions and uncertainties associated with the ongoing coronavirus pandemic (“COVID-19”)
and COVID-19 control responses.
Receivables
and Credit Policy
Trade
receivables from customers are uncollateralized customer obligations due under normal trade terms, primarily requiring payment before
product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to
the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice.
The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net
30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is
provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for
much we will bill the customer via credit card. As a result, the Company believes that its accounts receivable credit risk exposure is
limited, and it has not experienced any significant write-downs in its accounts receivable balances. As of September 30, 2022, and December
31, 2021, the Company had no allowance for bad debt.
Capitalized
Software
The
Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance
with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s
intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s
design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility
were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the
software. We expect an estimated useful life of five years for this product.
Inventory
Our
inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification
method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving
inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life
cycles, and estimated inventory levels. No provisions were determined as needed as of September 30, 2022 and as of December 31, 2021.
As
of September 30, 2022 and December 31, 2021, the Company recorded an inventory prepayment in the amount of $197,750 and $64,715, respectively,
related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after September 30,
2022 and December 31, 2021, respectively.
Intangible
Assets
Intangible
assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility
and design patents. The Company amortizes these assets over the estimated useful life of the patents.
The
Company reviews its intangibles assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets
may not be recoverable.
Property
and Equipment
Property
and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation
expense for the three and nine months ended September 30, 2022, was $4,667 and $12,566, respectively, as compared to $0 for the same
periods in 2021. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed
as incurred.
Income
Taxes
The
Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on
the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in
effect in the years in which the differences are expected to reverse.
The
Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected
to be taken, in a tax return. The guidance relates to, among other things, classification, accounting for interest and penalties associated
with tax positions, and disclosure requirements. Any interest and penalties accrued related to uncertain tax positions are recorded in
tax expense.
The
Company assesses the realizability of its net deferred tax assets. If, after considering all relevant positive and negative evidence,
it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the
net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including
the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.
Stock-Based
Compensation
The
Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation
expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards,
the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option
pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected
term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).
The
share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted,
using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for
U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.
Revenue
Recognition
Our
revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are
charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own
website Lucyd.co, and on Amazon.
To
determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance
obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations
in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods
or services promised within each contract and determine those that are performance obligations, and also assess whether each promised
good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance
obligation when (or as) the performance obligation is satisfied.
All
revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected
from customers on behalf of taxing authorities, returns, and discounts.
For
sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction
price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking
glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear
is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra
cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international
customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website
and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable
state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.
For
sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify
wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the
Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear
sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping
charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are
applicable.
For
sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order.
Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is
also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to
the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due
to the nature of wholesale distributor orders, no e-commerce fees are applicable.
The
Company’s sales do not contain any variable consideration.
We
allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason
within the first:
|
● |
7
days for sales made through our website (Lucyd.co) |
|
● |
30
days for sales made through Amazon |
|
● |
30
days for sales to wholesale retailers and distributors |
For
all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns,
which is recorded as a reduction of sales. Additionally, we reviewed all individual returns received in October 2022 pertaining
to orders processed prior to September 30, 2022. As a result, the Company determined that an allowance for sales returns was necessary.
The Company recorded $22,266 in allowance for sales returns as of December 31, 2021 and $12,604 as of September 30, 2022.
Shipping
and Handling
Costs
incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a
customer for shipping and handling are reported as revenues.
NOTE
3 – LIQUIDITY AND CAPITAL RESOURCES
The
Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions
in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions
may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer
taste including the economic impacts from the COVID-19 pandemic. These adverse conditions could affect the Company’s financial
condition and the results of its operations.
The
Company meets its day to day working capital requirements through monies raised through sales of eyewear and issuances of equity, including
past crowdfunding transactions, and more recently an initial public offering completed on August 2022. The Company also has issued a
convertible note held by its parent company. The Company’s forecasts and projections indicate that the Company expects to have
sufficient cash reserves and future income to operate within the level of its current facilities. The Company anticipates that its available
liquidity will be sufficient to fund operations through at least the end of 2023.
NOTE
4 – INCOME TAX PROVISION
At
the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year. This
estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.
Accordingly, the Company’s effective tax rate for the nine months ended September 30, 2022, was 0%, compared to the effective tax
rate of 0% for the nine months ended September 30, 2021. The Company’s effective tax rates for both periods were affected primarily
by a full valuation allowance on domestic net deferred tax assets.
NOTE
5 – INTANGIBLE ASSETS
Schedule of intangible assets | |
| | | |
| | |
| |
September 30, | | |
December 31, | |
Finite-lived
intangible assets | |
2022 | | |
2021 | |
Patent
Costs | |
$ | 135,421 | | |
$ | 95,480 | |
Intangible
assets, gross | |
| 135,421 | | |
| 95,480 | |
| |
| | | |
| | |
Less:
Accumulated amortization | |
| (15,233 | ) | |
| (8,174 | ) |
Intangible
assets, net | |
$ | 120,188 | | |
$ | 87,306 | |
Amortization
expense totaled $2,879 and $7,060 for the three and nine months ended September 30, 2022, as compared to $2,735 and $6,218 for the same
periods in 2021. Future amortization is expected to approximate $11,500 per year.
NOTE
6 – RELATED PARTY ADVANCES AND OTHER INTERCOMPANY AGREEMENTS
Convertible
Note and Due to Parent and Affiliates
During
the nine months ended September 30, 2022 and during 2021, the Company had the availability of, but not the contractual right to, intercompany
financing from the Parent and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).
The
convertible notes balances were $166,206 and $289,029 at September 30, 2022 and December 31, 2021, respectively. The change in the outstanding
balances was mainly due to working capital contributions from the Parent, offset by the partial conversion of the balance into equity.
On August 15, 2022, in connection with the Company’s initial public offering (see Note 10), Lucyd Ltd. converted $2,002,280 of
the $2,256,214 then outstanding on its convertible promissory note from the Company into 266,970 shares of our common stock, at an applicable
conversion price of $7.50 per share.
Management
Service Agreement
In
2020, the Company entered into a management services agreement with a related party (related through common ownership). The Company is
billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed
at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written
notice by any party.
The
related party provides the following services:
|
● |
Support
and advice to the Company in accordance with their area of expertise; |
|
● |
Research,
technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; |
|
● |
Advice,
assistance, and consultation services to support the Company or in relation to any other related matter |
During
the three and nine months ended September 30, 2022, the Company incurred $35,000 and $105,000, respectively, under its agreement with
Tekcapital Europe Ltd.
NOTE
7 – COMMITMENTS AND CONTINGENCIES
Legal
Matters
The
Company is not currently involved in or aware of threats of any litigation.
Leases
Our executive offices are located at 11900 Biscayne
Blvd., Suite 630 Miami, Florida 33181. Our executive offices are shared with the parent of our majority stockholder, Tekcapital, and
the Company is allocated 70% of the monthly rental costs, which is paid by the Parent and recorded as an increase in Due to Parent. We
consider our current office space adequate for our current operations.
Commitments
See
related party management services agreement discussed in Note 6.
In
July 2022, the Company entered into a license agreement which grants the Company the right to sell certain branded smart eyewear. The
license agreement requires the Company to pay royalties based on a percentage of net retail and wholesale sales, as defined. The license
agreement has a base term of 10 years but is cancellable at the option of the Company during the fifth year. The license agreement requires
guaranteed minimum royalty payments totaling approximately $1 million over the next five years, of which less than $25,000 is due during
the 2023 calendar year.
NOTE
8 – STOCK BASED COMPENSATION
No
option awards were granted during the nine months ended September 30, 2022.
Details
of the number of share options and the weighted average exercise price outstanding as of and during the nine months ended September 30,
2022 and are as follows:
Schedule of stock based compensation activity | |
| | | |
| | |
| |
Av.
Exercise
price per share | | |
Options | |
| |
$ | | |
(Number) | |
As
at January 1, 2022 | |
| 2.61 | | |
| 2,332,500 | |
Granted | |
| - | | |
| - | |
Exercised | |
| - | | |
| - | |
Forfeited | |
| - | | |
| - | |
As
at September 30, 2022 | |
| 2.61 | | |
| 2,332,500 | |
Exercisable
as at September 30, 2022 | |
| 2.48 | | |
| 911,500 | |
As
of September 30, 2022, unrecognized stock option expense of $1,744,675 remains to be recognized over next 1.64 years.
NOTE
9 – EARNINGS PER SHARE
The
Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number
of common shares outstanding during the respective period as required by ASC 260-10-50. As of September 30, 2022 and December 31, 2021,
all shares underlying the related party convertible debt and common stock options were excluded from the earnings per share calculation
due to their anti-dilutive effect.
Calculation
of net earnings per common share — basic and diluted:
Calculation of net earnings per common share - basic and diluted | |
| | | |
| | |
| |
For
the
Nine Months Ended | |
| |
September 30,
2022 | | |
September 30,
2021 | |
| |
(In thousands, except per share
amounts) | |
Basic
and diluted: | |
| | | |
| | |
Net
loss | |
| (3,804,692 | ) | |
| (1,859,094 | ) |
Weighted-average
number of common shares | |
| 6,266,709 | | |
| 5,033,823 | |
Basic
and diluted net income (loss) per common share | |
$ | (0.61 | ) | |
$ | (0.37 | ) |
NOTE
10 – INITIAL PUBLIC OFFERING
On
August 17, 2022, the Company closed on its initial public offering of 980,000 units consisting of 980,000 shares of its common stock
and 1,960,000 warrants to purchase 1,960,000 shares of common stock at a combined offering price of $7.50 per unit in exchange for gross
proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was
sold together with two warrants, each warrant exercisable to purchase one share of common stock at an exercise price of $7.50 per share.
In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or
warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the underwriter exercised
its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.
The
shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY”
and “LUCYW,” respectively.
Also,
pursuant to the terms of the underwriting agreement for the offering, the Company issued the underwriter certain other warrants to purchase
up to 58,800 shares of the Company’s common stock at an exercise price of $8.228 per share.
The
net proceeds received by the Company at closing amounted to $6,189,734. This amount was partially offset by $173,816 of previously deferred
offering costs, resulting in a net increase to stockholders’ equity of $6,015,918, of which $10 was recorded as an increase in
common stock and $6,015,908 was recorded as an increase to additional paid-in capital. The Company intends to use substantially all of
the net proceeds from the offering for advancing its sales and marketing, expanding inventory, updating and producing in-store displays,
developing new styles and sizes of the Company’s smart eyewear, and for working capital and other general corporate purposes.
NOTE 11 – SUBSEQUENT
EVENTS
On November 15, 2022,
the exercise price of the Warrants will adjust to be equal to the greater of $3.75 per share and 100% of the volume weighted average
price per share of common stock on November 14, 2022, provided that such value is less than $7.50 per share.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The
following discussion and analysis of our financial condition and results of operations should be read together with our financial statements
and the related notes and the other financial information included elsewhere in this Quarterly Report. This discussion contains forward-looking
statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors, including those discussed below and elsewhere in this Quarterly Report.
Overview
We
develop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives,
while also offering vision correction and protection. Our flagship product, Lucyd Lyte, enables the wearer to listen to music, take and
make calls, and use voice assistants to perform many common smartphone tasks hands-free. Innovative Eyewear owns the exclusive rights
to the Lucyd brand and the Lyte product line.
Our
mission is to Upgrade Your Eyewear. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection
together with digital connectivity and clear audio, while also offering a solution for listening to music outdoors (as compared to in-ear headphones).
The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear
use, offers a lifestyle upgrade at a price similar to traditional prescription eyewear.
After
the full launch of Lucyd Lyte in January 2021, we had strong interest and demand from customers in the U.S. and have since sold
thousands of our smart eyewear products. In order to meet the growing demand for our products, and in an effort to expand our reach,
we have engaged over 150 unique wholesale accounts. All of our products are designed in Miami, manufactured in Asia, and currently sold
through two major sales channels:
| (1) | e-commerce,
primarily via our website (Lucyd.co) and marketplaces such as Amazon, Bestbuy.com, and DicksSportingGoods.com. |
| (2) | a
growing network of independent eyewear stores. |
We
apply a manufacturer suggested retail price (“MSRP”) of $149 (for our standard frames) to $179 (for our titanium frames)
for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels, with our wholesale pricing
offering volume discounts to these prices. Please refer to discussion in the Components of Results of Operations section below for more
details regarding our pricing structure.
We
are gearing-up to expand these channels with national eyewear chains, big box retail stores (electronics, sporting goods, general
merchandise) and specialty retail stores.
We
view this business model as being more efficient with regards to the deployment of capital, by electing not to build our own manufacturing
facilities and Company-owned retail distribution, but rather contract with existing sources of production and consumer facing retail
distribution.
In
July 2022, the Company entered into a license agreement which grants the Company the right to sell certain branded smart eyewear. The
license agreement requires the Company to pay royalties based on a percentage of net retail and wholesale sales, as defined. The license
agreement has a base term of 10 years but is cancellable at the option of the Company during the fifth year. The license agreement requires
guaranteed minimum royalty payments totaling approximately $1 million over the next five years, of which less than $25,000 is due during
the 2023 calendar year.
Impact
of COVID-19 on Our Business
On
March 11, 2020, the World Health Organization officially declared the outbreak of the COVID-19 virus a “pandemic.”
This contagious disease outbreak has continued to spread across the globe and is impacting worldwide economic activity and financial
markets. In light of the uncertain and rapidly evolving situation relating to the spread of COVID-19, we took precautionary measures
intended to minimize the risk of the virus to our employees, by following the CDC guidelines. Specifically, we set up a system that enabled
our employees to work remotely when it was beneficial for them or when they felt ill. Additionally, precautionary measures that have
been adopted may negatively affect our ability to sell our products. This includes, for example, reducing the marketplace traction at
trade shows, and retail store traffic for our re-sellers, and the fulfilment of customer orders with customized lenses, shipping delays
and other operations of our suppliers and fulfilment partners. Additionally, our product is manufactured in China and shipped from China
on a regular basis. We have not experienced substantial delays in manufacturing or shipping due to COVID-19; however, we are exposed
to such risk in the future as a potential impact of COVID-19. More generally, the outbreak of COVID-19 could adversely affect economies
and financial markets globally, potentially leading to an economic downturn, which could decrease consumer spending and adversely affect
demand for our products. It is not possible at this time to estimate the impact that COVID-19 could have on our business, as the
impact will depend on future developments, which are highly uncertain and cannot be predicted.
Key
Factors Affecting Performance
Expansion
of retail points of purchase
Our
future depends in large part on our ability to place Lucyd Lyte in optical stores as well as sporting goods stores and other specialty
stores. To address this, we assembled a team with decades of experience in the eyewear industry and are offering a strong co-op marketing
program and re-ordering incentives program. We currently have 16 different styles available and plans to continuously increase this number
over time.
Retail
store client retention and re-orders
Our
ability to sustain and increase revenue depends in large part on our ability to receive re-orders from stores, either directly or
through our wholesale distributors. To support our sales to retail stores directly, we offer a strong co-op marketing program that
includes free and paid store display materials. As part of this strategy, we have launched a digital try-on kiosk for our resellers
to help educate their in-store customers about Lucyd Lyte and enable customers to try them on in a contact-less manner, to
mitigate customer contact with viral pathogens.
Investing
in business growth
We
believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about
the shape, size, and design of their eyewear, we aim to continuously invest in the design and development of new models in an effort
to provide the consumer with a wide selection of styles, colors, and finishes.
We
also intend to invest in co-op marketing with retail stores and expand our sales and marketing team (including influencers) to broaden
our brand awareness and online presence. We will also increase our general and administrative expenses in the foreseeable future to cover
the additional costs for finance, compliance, supply chain, quality assurance, and investor relations as we grow as a public company.
Key
Performance Indicators
Store
Count (B2B)
We
believe that one of the key indicators for our business is the number of retail stores onboarded to sell Lucyd Lyte. We started onboarding
our first retail stores in June 2021. Currently, we have over 250 retail stores selling Lucyd Lyte primarily in the United States
and Canada.
Based
on the existing demand for our products, current distribution, and recently consummated supply agreements, we anticipate that our products
will be available in a significant number of new third-party retail locations for the remainder of 2022 and 2023.
Re-order
ratio (B2B)
Many
of the retail stores that placed initial stocking orders, either directly or through our wholesale distributors, have also placed follow-on orders
in the few short months since launching our wholesale business in June 2021. As of September 30, 2022, 27.7% of stores have re-ordered our
product. We expect this number to gradually increase as we roll out our co-op marketing program and introduce more of our virtual
try-on kiosks into retail stores, to facilitate customer education and product sell-through.
Number
of online orders (B2C)
For
our e-commerce business, we track the number of online orders as an indicator of the success of our online marketing efforts. As of September
30, 2022, we received a total of over 10,435 orders from customers online. We believe that the addition of new styles, as well as further
investment in brand awareness, product ambassadors, and influencer campaigns, will enable continued growth of online orders in the foreseeable
future. We expect to allocate a significant portion of our advertising expenditures towards influencer marketing programs.
Components
of Results of Operations
Net
Revenue
Our
revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which
are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, and
on our own website Lucyd.co and on Amazon.
We
apply a manufacturer suggested retail price (“MSRP”) of $149 (for our standard frames) to $179 (for our titanium frames)
for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. U.S. consumers enjoy free
USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon.
For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges. Any costs associated with fees
charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers. We charge applicable state
sales taxes in addition to the MSRP for both online channels and all other marketplaces on which sell.
Our
wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts to the MSRP, due to the nature
of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature
of wholesale retail orders, no e-commerce fees are applicable.
Our
prescription lens prices range from $35 for a basic clear single vision lens, up to $415 for a Transitions® progressive signature
colorized lens, which is charged in addition to the MSRP. Glasses with prescription lenses are only available through our website Lucyd.co,
while our sales through Amazon and to our retail partners only include non-prescription glasses.
Cost
of Goods Sold
Cost
of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.
For
retail sales placed on one of our e-commerce channels, these costs include (i) product costs held at the lesser of cost and net
realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, (iii) optical laboratory
costs for RX glasses, (iv) merchant fees, (v) fees paid to third-party e-commerce platforms, and (vi) cost of shipping the
product to the consumer.
For
wholesale sales these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventory
reserves, (ii) freight, import, and inspection costs, and (iii) credit card fees.
When
consumers place their orders directly on our online store, our cost of goods sold on a per-unit basis is approximately 8% lower
than when consumers place their orders directly from third-party platforms.
We
expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting
demand, customer shipping costs, and management of our inventory and merchandise mix.
Over
time we expect our total cost of goods sold on a per unit basis to decrease as a result of an increase in scale. Increase in scale is
achieved as a result of increase in volumes from both business to consumer and business to business (retail store) orders. We continue
to expand our products with line extensions and new models and broaden our presence in retail stores carrying our products.
Gross
Profit and Gross Margin
We
define gross profit as net revenues less cost of goods sold. Gross margin is gross profit expressed as a percentage of net revenues.
Our gross margin may fluctuate in the future based on a number of factors, including the cost at which we can obtain, transport, and
assemble our inventory, the rate at our vendor network expands, and how effective we can be at controlling costs, in any given period.
We
anticipate our cost of goods sold, on a per unit basis, will decrease with scale, and this will likely have a positive impact on our
gross margins.
Operating
Expenses
Our
operating expenses consist primarily of:
| ● | general &
administrative expenses that include primarily consulting and payroll expenses, IT &
software, legal, stock compensation expense, postage and non-customer product shipping,
and other administrative expense; |
| ● | sales
and marketing expenses including cost of online and TV advertising, marketing agency fees,
influencers, trade shows, and other initiatives; |
| ● | related
party management fees for a range of back-office services provided by Lucyd Ltd.; |
| ● | research
and development expenses related to (i) development of new styles and features of our
smart eyewear, (ii) development and improvement of our e-commerce website, and (iii) development
of our Vyrb social media app for wearables. |
Interest
and Other Income, Net
Interest
and other income, net, consists primarily of interest expense paid on convertible note loan due to the Parent.
Provision
for Income Taxes
Provision
for income taxes consists of income taxes related to foreign and domestic federal and state jurisdictions in which we conduct business,
adjusted for allowable credits, deductions, and valuation allowance against deferred tax assets.
Results
of Operations
Three
Months Ended September 30, 2022 and 2021
The
following table summarizes our results of operations for the three months ended September 30, 2022 and 2021:
| |
Three months
ended
September 30,
2022 | | |
| | |
Three months
ended
September 30,
2021 | | |
| | |
Change between
the
three months ended
September 30,
2022
and 2021 | | |
| |
Revenues,
net | |
$ | 151,957 | | |
100 | % | |
$ | 171,033 | | |
100 | % | |
$ | (19,076 | ) | |
-11 | % |
Less:
Cost of Goods Sold | |
| (129,092 | ) | |
85 | % | |
| (130,223 | ) | |
76 | % | |
| 1,131 | | |
-1 | % |
Gross
profit/(loss) | |
| 22,865 | | |
15 | % | |
| 40,810 | | |
24 | % | |
| (17,945 | ) | |
-44 | % |
| |
| | | |
| | |
| | | |
| | |
| | | |
| |
Operating
Expenses: | |
| | | |
| | |
| | | |
| | |
| | | |
| |
General
and administrative | |
| (479,983 | ) | |
316 | % | |
| (584,927 | ) | |
342 | % | |
| 104,944 | | |
-18 | % |
Sales
and marketing | |
| (568,901 | ) | |
374 | % | |
| (512,937 | ) | |
300 | % | |
| (55,964 | ) | |
11 | % |
Research
& development | |
| (304,691 | ) | |
201 | % | |
| (9,224 | ) | |
5 | % | |
| (295,467 | ) | |
3203 | % |
Related
party management fee | |
| (35,000 | ) | |
23 | % | |
| (25,000 | ) | |
15 | % | |
| (10,000 | ) | |
40 | % |
Total
Operating Expenses | |
| (1,388,575 | ) | |
914 | % | |
| (1,132,088 | ) | |
662 | % | |
| (256,487 | ) | |
23 | % |
| |
| | | |
| | |
| | | |
| | |
| | | |
| |
Other
Income | |
| (735 | ) | |
| | |
| - | | |
| | |
| (735 | ) | |
| |
Interest
Expense | |
| (37,876 | ) | |
25 | % | |
| (9,502 | ) | |
6 | % | |
| (28,374 | ) | |
299 | % |
Total
Other (Expense) | |
| (38,611 | ) | |
25 | % | |
| (9,502 | ) | |
6 | % | |
| (29,109 | ) | |
306 | % |
| |
| | | |
| | |
| | | |
| | |
| | | |
| |
Net
Loss | |
$ | (1,404,321 | ) | |
924 | % | |
$ | (1,100,780 | ) | |
644 | % | |
$ | (303,541 | ) | |
28 | % |
Revenue
Our
revenues for the three months ended September 30, 2022, were $151,957 as compared to revenues of $171,033 during the three months ended
September 30, 2021. Our revenue is generated entirely from sales of eyewear products, namely smart frames, lenses, and accessories. The
decrease in revenue was due to several factors, including the Company focusing more efforts on product line improvements, licensing deals
and team expansion during the period, increases in digital advertising costs, and changes in consumer spending habits due to an uncertain
economic climate.
For
the three months ended September 30, 2022, approximately 48.9% of sales were processed on our online store (Lucyd.co), 26.1% on Amazon
and 25% with reseller partners. This sales channel mix impacted our revenue for the period, due to the fact we charge additional $35
to $275 for our prescription lenses available only on Lucyd.co. For the three months ended September 30, 2022, we generated $91,661 of
revenue from sales of non-prescription frames and accessories and $22,706 was generated from sales of frames with prescription lenses.
All of the $ 33,432 in sales generated on Amazon.com during the period were for non-prescription frames and accessories as we only offer
prescription lenses through our website. Of the $80,934 in online sales generated through Lucyd.co, $22,706 related to frames with prescription
lenses and $58,228 of glasses sold were with non-prescription lenses. E-commerce sales are the most material portion of our sales to
date.
We
expect that the online portion of our sales will gradually decrease on a percentage basis but remain an important component of our total
sales as we onboard more retail stores. We pursued growth in retail store segment in the year ended 2021 and since the beginning of 2022,
growing our retail store presence to over 200 stores as of September 30, 2022.
Cost
of goods sold
Our
total cost of goods sold decreased to $129,092 for the three months ended September 30, 2022, as compared to $130,222 for the three months
ended September 30, 2021. The decrease being mainly attributable to a lower cost in frames. These items included, but were not limited
to, the cost of frames of $89,768, cost of prescription lenses incurred with our third-party vendor of $15,482, and affiliate referral
fees, sales commission expense, and e-commerce platform fees of $23,719 for the three months period ended September 30, 2022. Out of
$129,092 of our total cost of goods sold for the three months ended September 30, 2022, $15,482 related to orders with prescription lenses,
while $113,610 pertained to non-prescription orders.
Over
time, we expect third-party retail stores to become our primary sales channel as we on-board additional stores. Consequently, we expect
sales of prescription lens, offered through our website, to decrease as our third-party retail partners outfit our Lyte frames with more
prescriptions. As a result, over time we expect prescription lens costs to gradually decrease as a percentage of our overall cost of
goods sold.
We
anticipate growth in both wholesale and e-commerce channel sales in the remainder of 2022 and in 2023, and we also expect corresponding
growth in total cost of goods sold, primarily from additional product-related costs.
Gross
profit
Our
gross profit was $22,865 for the three months ended September 30, 2022, as compared to $40,810 for the three months ended September 30,
2021. This decrease was primarily due to a large number of products provided at promotional pricing to consumers and retailers to encourage
market share growth, as well as increased shipping costs compared to previous years. We expect gross profit for the fiscal year ending
December 31, 2022, to improve slightly, primarily due to economies of scale from large, anticipated orders. As we expect retail stores
to become our primary sales channel as we onboard new stores, we also expect our overall gross margin to approximate that of the wholesale
channel, where no e-commerce platform fees or prescription lens cost apply, and volume-related price discounts are included.
Operating
expenses
Our
operating expenses increased to $1,388,575 for the three months ended September 30, 2022, as compared to $1,132,090 for the three months
ended September 30, 2021. This increase was primarily due to the expansion of our business following the launch of Lucyd Lyte in January
2021 and included, but was not limited to, the following:
General
and administrative expenses
Our
general and administrative expenses decreased to $479,983 for the three months ended September 30, 2022, as compared to $584,927 for
the three months ended September 30, 2021. This decrease was primarily due to a reclass of stock-based compensation in the amount of
$209,849 to research and development expenses. We also spent $56,000 on public & investor relations.
Sales
and marketing expenses
Our
sales and marketing expenses increased to $568,901 for the three months ended September 30, 2022, as compared to $512,938 for the three
months ended September 30, 2021. The increase was primarily due to our multi-prong sales and marketing approach, growing continuously
over 2021 and in the first quarter of 2022 after the launch of the main product in 2021, including the costs of online advertising of
$217,108, influencer costs of $22,431 and trade shows of $48,680. We also hired four sales & marketing staff and booked $87,009 in
related stock compensation expense for the period.
We
anticipate these costs to further increase as we continue to invest in and build our brand, expand the number of e-commerce platforms
we sell our products on and invest in retail store co-op marketing programs to help educate our in-store customers about Lucyd
Lytes, and increase our brand’s physical presence and role in the eyewear industry.
Related
party management fee
Our
related party management fee was $35,000 for the three months ended September 30, 2022, as compared to $25,000 for the three months ended
September 30, 2021. The increase was due to increased scope of assistances received under the agreement, corresponding to continuous
scale-up of Company’s operations after launch of its flagship product in the first quarter of 2021. The management fees are related
to the management services agreement between us and an affiliate of our Parent.
Research
and development costs
Our
research and development costs increased to $304,691 for the three months ended September 30, 2022, as compared to $9,224 for the three
months ended September 30, 2021. This increase was primarily due to a reclass of stock-based compensation in the amount of $209,849 from
general and administrative expenses. Also, the increased cost of new frame development by $81,485, as the Company continued to expand
its product line after the flagship product was launched in the first quarter of 2021.
Nine
Months Ended September 30, 2022 and 2021
| |
Nine months
ended
September 30,
2022 | | |
| | |
Nine months
ended
September 30,
2021 | | |
| | |
Change between
the
six months ended
September 30,
2022
and 2021 | | |
| |
Revenues,
net | |
$ | 592,720 | | |
100 | % | |
$ | 415,185 | | |
100 | % | |
$ | 177,535 | | |
43 | % |
Less:
Cost of Goods Sold | |
| (452,218 | ) | |
76 | % | |
| (332,378 | ) | |
80 | % | |
| (119,840 | ) | |
29 | % |
Gross
profit/(loss) | |
| 140,502 | | |
24 | % | |
| 82,807 | | |
20 | % | |
| 57,695 | | |
14 | % |
| |
| | | |
| | |
| | | |
| | |
| | | |
| |
Operating
Expenses: | |
| | | |
| | |
| | | |
| | |
| | | |
| |
General
and administrative | |
| (1,797,091 | ) | |
303 | % | |
| (883,356 | ) | |
213 | % | |
| (913,735 | ) | |
220 | % |
Sales
and marketing | |
| (1,545,615 | ) | |
261 | % | |
| (903,795 | ) | |
218 | % | |
| (641,820 | ) | |
155 | % |
Research
& development | |
| (393,058 | ) | |
66 | % | |
| (36,121 | ) | |
9 | % | |
| (356,937 | ) | |
86 | % |
Related
party management fee | |
| (105,000 | ) | |
18 | % | |
| (84,975 | ) | |
20 | % | |
| (20,025 | ) | |
5 | % |
Total
Operating Expenses | |
| (3,840,764 | ) | |
648 | % | |
| (1,908,247 | ) | |
460 | % | |
| (1,932,517 | ) | |
465 | % |
| |
| | | |
| | |
| | | |
| | |
| | | |
| |
Other
Income | |
| (3,293 | ) | |
1 | % | |
| - | | |
| | |
| (3,293 | ) | |
1 | % |
Interest
Expense | |
| (101,137 | ) | |
17 | % | |
| (33,654 | ) | |
8 | % | |
| (67,483 | ) | |
16 | % |
Total
Other (Expense) | |
| (104,430 | ) | |
18 | % | |
| (33,654 | ) | |
8 | % | |
| (70,776 | ) | |
17 | % |
| |
| | | |
| | |
| | | |
| | |
| | | |
| |
Net
Loss | |
$ | (3,804,692 | ) | |
642 | % | |
$ | (1,859,094 | ) | |
448 | % | |
$ | (1,945,598 | ) | |
469 | % |
Revenue
Our
revenues for the nine months ended September 30, 2022, were $592,720 as compared to revenues of $415,185 during the nine months ended
September 30, 2021. Our revenue is generated entirely from sales of eyewear products, namely smart frames, lenses, and accessories. The
increase in revenue was due to the launch of Lucyd Lytes in January 2021, and subsequent scale-up of sales and marketing activities leading
up to more product awareness.
For
the nine months ended September 30, 2022, approximately 33.6% of sales were processed on our online store (Lucyd.co), 29.6% on Amazon,
and 36.8% with reseller partners. This sales channel mix impacted our revenue for the period, due to the fact we charge an additional
$35 to $275 for our prescription lenses available only on Lucyd.co. For the nine months ended September 30, 2022, we generated $460,073
of revenue from sales of non-prescription frames and accessories and $95,057 was generated from sales of frames with prescription lenses.
All of the $175,269.2 in sales generated on Amazon.com during the period were for non-prescription frames and accessories as we only
offer prescription lenses through our website. Of the $197,437 in online sales generated through Lucyd.co, $95,058 related to frames
with prescription lenses and $102,380 of glasses sold were with non-prescription lenses. E-commerce sales are the most material portion
of our sales to date.
We
expect that the online portion of our sales will gradually decrease on a percentage basis but remain an important component of our total
sales as we onboard more retail stores. We pursued growth in retail store segment in the year ended 2021 and during 2022, growing our
retail store presence to over 200 stores as of September 30, 2022.
Cost
of goods sold
Our
total cost of goods sold increased to $452,218 for the nine months ended September 30, 2022, as compared to $332,378 for the nine months
ended September 30, 2021. This increase mirrors the increase in underlying sales discussed above. These items included, but were not
limited to, the cost of frames of $285,586, cost of prescription lenses incurred with our third-party vendor of $70,563, and affiliate
referral fees, sales commission expense, and e-commerce platform fees of $93,706 for the nine months ended September 30, 2022. Out of
$452,218 of our total cost of goods sold for the nine months ended September 30, 2022, $79,370 related to orders with prescription lenses,
while $372,848 pertained to non-prescription orders.
For
the nine months ended September 30, 2022, approximately 33.6% of sales were processed on our online store (Lucyd.co), 29.6% on Amazon,
and 36.8% from reseller partners. This sales channel mix impacted our cost of goods sold, as the cost of prescription lenses attributable
to our Lucyd.co sales increased our cost of goods sold through Lucyd.co while not impacting cost of goods sold for sales realized through
Amazon or retail store partners.
Over
time, we expect third-party retail stores to become our primary sales channel as we onboard additional stores. Consequently, we expect
sales of prescription lens, offered through our website to decrease, as our third-party retail partners outfit our Lyte frames with more
prescriptions. As a result, over time we expect prescription lens costs to gradually decrease as a percentage of our overall cost of
goods sold.
We
anticipate growth in both wholesale and e-commerce channel sales in the remainder of 2022 and in 2023, and we also expect corresponding
growth in total cost of goods sold, primarily from additional product related costs.
Gross
profit
Our
gross profit increased to $140,502 for the nine months ended September 30, 2022, as compared to $82,807 for the nine months ended September
30, 2021. This increase was due to the difference in the price of Lucyd Lytes versus products available for sale in the third quarter
of 2021, with new models introduced at higher prices after the first quarter of 2021. We expect gross profit for the fiscal year ending
December 31, 2022, to improve slightly, primarily due to economies of scale from large, anticipated orders. As we expect retail stores
to become our primary sales channel as we on board new stores, we also expect our overall gross margin to approximate that of the wholesale
channel, where no e-commerce platform fees or prescription lens cost apply, and volume-related price discounts are included.
Operating
expenses
Our
operating expenses increased to $3,840,764 for the nine months ended September 30, 2022, as compared to $1,908,247 for the nine months
ended September 30, 2021. This increase was primarily due to the expansion of our business following the launch of Lucyd Lyte in January
2021 and included, but was not limited to, the following:
General
and administrative expenses
Our
general and administrative expenses increased to $1,797,091 for the nine months ended September 30, 2022, as compared to $883,356 for
the nine months ended September 30, 2021. This increase was primarily due to an increase of stock option awards issued in 2021, resulting
from increase in our staffing of $234,522. Also, as a result of Company’s growth and increased used of consultants, consulting
fees increased from $209,330 to $345,560. Further, there has been an increase Audit & Accountancy fees from $68,696 to $126,001 and
we spent $56,000 on public & investor relations.
Sales
and marketing expenses
Our
sales and marketing expenses increased to $1,545,615 for the nine months ended September 30, 2022, as compared to $903,795 for the nine
months ended September 30, 2021. The increase was primarily due to our multi-prong sales and marketing approach, growing continuously
over 2021 and in the nine months of 2022 after the launch of our main product in 2021, including the costs of online advertising of $1,019,916,
influencer costs of $60,113 and trade shows of $128,779. We also hired four sales & marketing staff and booked $281,953 in related
stock compensation expense for the period.
We
anticipate these costs to further increase as we continue to invest in and build our brand, expand the number of e-commerce platforms
we sell our products on, invest in retail store co-op marketing programs to help educate our in-store customers about Lucyd
Lytes, and increase our brand’s physical presence and role in the eyewear industry.
Related
party management fee
Our
related party management fee was $105,000 for the nine months ended September 30, 2022, as compared to $84,975 for the nine months ended
September 30, 2021. The increase was due to increased scope of assistances received under the agreement, corresponding to continuous
scale-up of Company’s operations after launch of its flagship product in the first quarter of 2021. The management fees are related
to the management services agreement between us and an affiliate of our Parent.
Research
and development costs
Our
research and development costs increased to $393,058 for the nine months ended September 30, 2022, as compared to $36,121 for the nine
months ended September 30, 2021. The increase was primarily due to a reclass of stock-based compensation in the amount of $209,849 from
general and administrative expenses in addition to the increased cost of new frame development as the Company continued to expand its
product line after the flagship product was launched in the first quarter of 2021.
Liquidity
and Capital Resources
Cash
Flow Data:
| |
Nine months
ended | | |
Nine months
ended | |
| |
September 30, | | |
September 30, | |
| |
2022 | | |
2021 | |
Net
cash flows from operating activities | |
$ | (1,995,678 | ) | |
$ | (810,446 | ) |
Net
cash flows from investing activities | |
| (155,428 | ) | |
| (87,246 | ) |
Net
cash flows from financing activities | |
| 7,047,603 | | |
| 935,725 | |
Net
Change in Cash | |
$ | 4,896,497 | | |
$ | 38,033 | |
Initial
Public Offering
On
August 17, 2022, the Company closed on its initial public offering of 980,000 units, consisting of 980,000 shares of its common stock
and 1,960,000 warrants to purchase 1,960,000 shares of common stock, at a combined offering price of $7.50 per unit in exchange for gross
proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was
sold together with two warrants, each warrant to purchase one share of common stock at an exercise price of $7.50 per share. In addition,
the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to
purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the underwriter exercised its option to
purchase additional warrants to purchase 294,000 shares of common stock.
After
deducting underwriting discounts and offering expenses, net proceeds received by the Company amounted to $6,189,734. We intend to use
proceeds from this offering primarily on (i) sales and marketing, (ii) expanding our inventory, (iii) updating and developing our in-store
displays, (iv) developing new smart eyewear styles and sizes, as well as further development and commercialization of the Vyrb app, and
(v) working capital and other general corporate purposes.
We
expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our
business. We believe our existing cash and cash equivalents, proceeds from the aforementioned offering, funds available under our existing
credit facility, and cash flows from operating activities will be sufficient to fund our operations for at least the next twelve months.
However,
our future capital requirements will depend on many factors, including, but not limited to, growth in the number of retail store customers,
the needs of our e-commerce business and retail distribution network, expansion of our product and software offerings, and the timing
of investments in technology and personnel to support the overall growth of our business. To the extent that current and anticipated
future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional
equity or debt financing. The sale of additional equity would result in additional dilution to our stockholders. The incurrence of debt
financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing
covenants that would restrict our operations. There can be no assurances that we will be able to raise additional capital. In the event
that additional financing is required from outside sources, we may not be able to negotiate terms acceptable to us or at all. The recent
COVID-19 pandemic along with other geopolitical and macroeconomic factors has caused disruption in the global financial markets, which
could reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to raise additional capital
when required, or if we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient
capital, our business, results of operations, financial condition, and cash flows would be adversely affected.
Off-Balance
Sheet Arrangements
As
of September 30, 2022, we did not have any off-balance sheet arrangements.
Critical
Accounting Policies and Significant Developments and Estimates
Management’s
discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared
in accordance with GAAP. The preparation of our financial statements requires us to make estimates and assumptions that affect the reported
amounts of assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred
during the reporting periods, as well as related disclosures. Our estimates are based on our historical experience and on various other
factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying
value of assets and liabilities and the amount of revenue and expenses that are not readily apparent from other sources. Actual results
may differ from these estimates under different assumptions or conditions, and any such differences may be material. We believe that
the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate
to the more significant areas involving management’s judgments and estimates.
We
believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically re-evaluate
these accounting policies and estimates and make adjustments when facts and circumstances dictate a change. Historically, we have found
our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using
necessary estimates.
Inventory
Our
inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific
identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess,
obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted
sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed at September 30, 2022
and as of December 31, 2021.
As
of September 30, 2022 and December 31, 2021, the Company recorded an inventory prepayment in the amount of $197,750 and $64,715,
respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after
September 30, 2022 and December 31, 2021, respectively.
Intangible
Assets
Intangible
assets relate to:
| ● | Internally-developed
and licensed utility and design patents. We amortize these assets over the estimated useful
life of the patents. |
| ● | Capitalized
software costs incurred due to development of the Vyrb app. We amortize these assets over
the estimated useful life of the software application. |
We
review our intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not
be recoverable.
Income
Taxes
We
are taxed as a C corporation. We comply with Financial Accounting Standards Board (FASB) ASC 740 for accounting for uncertainty in income
taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financial
statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized,
a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance
on derecognition, classification, interest and penalties, accounting in interim periods, and disclosure. Based on our evaluation, we
have concluded that there are no significant uncertain tax positions requiring recognition in our financial statements. We believe that
our income tax positions would be sustained on audit and do not anticipate any adjustments that would result in a material change to
the Company’s financial position.
We
have incurred taxable losses since inception but are current in our tax filing obligations. We are not presently subject to any income
tax audit in any taxing jurisdiction.
Stock-Based Compensation
We
account for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation
expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards,
the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option
pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected
term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).
The
share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted,
using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates
for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.
The
fair value of common stock used in the option pricing model in 2020 and 2021 was determined using the most recent price paid by independent
investors through Regulation Crowdfund (“REG CF”) securities offerings undertaken by the Company. For a majority of the time
during which stock option awards were granted by the Company in 2021 and 2020, the Company had been raising funds from investors under
Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors. Specifically,
(i) from June 2020 to April 2021, the Company was conducting a REG CF offering of its shares of common stock at a price of $1 per share,
and the Company utilized this $1 per share price to issue and value its stock-based awards during such period, and (ii) from May
2021 to September 2021, the Company was conducting a second REG CF offering of its shares of common stock at a price of $3.56 per share,
and the Company utilized this $3.56 per share price to issue and value its stock-based awards during such period.
The
pre-money valuation determining price per share was agreed upon each time with the crowdfund platform, who has great deal of experience
in setting the proper pre-money valuations for companies that list on their platforms. The determination was made using Company’s
business progress.
Revenue
Recognition
Our
revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which
are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, and
on our own website Lucyd.co and on Amazon.
To
determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify
the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to
the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract
inception, we assess the goods or services promised within each contract, determine those that are performance obligations, and assess
whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated
to the respective performance obligation when (or as) the performance obligation is satisfied.
All
revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected
from customers on behalf of taxing authorities, returns, and discounts.
For
sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and
transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light
blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation
when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available
for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international
customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website
and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable
state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.
For
sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify
wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation which is delivery of our
eyewear products to the retail store and also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail
store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding
any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.
For
sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order.
Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is
also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to
the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due
to the nature of wholesale distributor orders, no e-commerce fees are applicable.
The
Company’s sales to both retail partners and through our e-commerce channels do not contain any variable consideration.
We
allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason
within the first:
| ● | 7
days for sales made through our website (Lucyd.co) |
| ● | 30
days for sales made through Amazon |
| ● | 30
days for sales to wholesale retailers and distributors |
For
all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns,
which is recorded as a reduction of sales. Additionally, we reviewed all individual returns received in October 2022 pertaining to orders
processed prior to September 30, 2022. As a result, the Company determined that an allowance for sales returns was necessary. The Company
recorded $22,266 in allowance for sales returns as of December 31, 2021 and $12,604 as of September 30, 2022.
Shipping
and Handling
Costs
incurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized. Amounts billed to
a customer for shipping and handling are reported as revenues.
Earnings/loss
per share
The
Company presents earnings and loss per share data by calculating the quotient of earnings/(loss) divided by the weighted average
number of common shares outstanding during the period as required by ASC 260-10-50. As of September 30, 2022 and December 31,
2021, all shares underlying the related party convertible debt and common stock options were excluded from the earnings per share calculation,
due to their anti-dilutive effect.